{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:21:58Z","timestamp":1761110518454,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T00:00:00Z","timestamp":1587340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T00:00:00Z","timestamp":1587340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2017R1D1A1B03029050"],"award-info":[{"award-number":["2017R1D1A1B03029050"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI14C1324"],"award-info":[{"award-number":["HI14C1324"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s00296-020-04579-4","type":"journal-article","created":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T07:02:48Z","timestamp":1587366168000},"page":"1089-1099","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Hyperuricemia is associated with decreased renal function and occurrence of end-stage renal disease in patients with microscopic polyangiitis and granulomatosis with polyangiitis: a retrospective study"],"prefix":"10.1007","volume":"40","author":[{"given":"Hyeok Chan","family":"Kwon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Soo","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung-Woo","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juyoung","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Min","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason Jungsik","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Beom","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,20]]},"reference":[{"key":"4579_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA et al (2013) 2012 Revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65:1\u201311. https:\/\/doi.org\/10.1002\/art.37715","journal-title":"Arthritis Rheum"},{"key":"4579_CR2","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrrheum.2014.104","volume":"10","author":"CG Kallenberg","year":"2014","unstructured":"Kallenberg CG (2014) Key advances in the clinical approach to ANCA-associated vasculitis. Nat Rev Rheumatol 10:484\u2013493. https:\/\/doi.org\/10.1038\/nrrheum.2014.104","journal-title":"Nat Rev Rheumatol"},{"key":"4579_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrneph.2013.225","volume":"10","author":"U Schonermarck","year":"2014","unstructured":"Schonermarck U, Gross WL, de Groot K (2014) Treatment of ANCA-associated vasculitis. Nat Rev Nephrol 10:25\u201336. https:\/\/doi.org\/10.1038\/nrneph.2013.225","journal-title":"Nat Rev Nephrol"},{"key":"4579_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/ckj\/sfv020","volume":"8","author":"OO Rowaiye","year":"2015","unstructured":"Rowaiye OO, Kusztal M, Klinger M (2015) The kidneys and ANCA-associated vasculitis: from pathogenesis to diagnosis. Clin Kidney J 8:343\u2013350. https:\/\/doi.org\/10.1093\/ckj\/sfv020","journal-title":"Clin Kidney J"},{"key":"4579_CR5","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/ndt\/gfw046","volume":"32","author":"S Moiseev","year":"2017","unstructured":"Moiseev S, Novikov P, Jayne D, Mukhin N (2017) End-stage renal disease in ANCA-associated vasculitis. Nephrol Dial Transplant 32:248\u2013253. https:\/\/doi.org\/10.1093\/ndt\/gfw046","journal-title":"Nephrol Dial Transplant"},{"key":"4579_CR6","doi-asserted-by":"publisher","first-page":"674","DOI":"10.3899\/jrheum.120879","volume":"40","author":"JG Lieberthal","year":"2013","unstructured":"Lieberthal JG, Cuthbertson D, Carette S et al (2013) Urinary biomarkers in relapsing antineutrophil cytoplasmic antibody-associated vasculitis. J Rheumatol 40:674\u2013683. https:\/\/doi.org\/10.3899\/jrheum.120879","journal-title":"J Rheumatol"},{"key":"4579_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/rheumatology\/ken500","volume":"48","author":"M Chen","year":"2009","unstructured":"Chen M, Wang F, Zhao MH (2009) Circulating neutrophil gelatinase-associated lipocalin: a useful biomarker for assessing disease activity of ANCA-associated vasculitis. Rheumatology (Oxford) 48:355\u2013358. https:\/\/doi.org\/10.1093\/rheumatology\/ken500","journal-title":"Rheumatology (Oxford)"},{"key":"4579_CR8","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1093\/ndt\/gfh161","volume":"19","author":"S Weidner","year":"2004","unstructured":"Weidner S, Geuss S, Hafezi-Rachti S, Wonka A, Rupprecht HD (2004) ANCA-associated vasculitis with renal involvement: an outcome analysis. Nephrol Dial Transplant 19:1403\u20131411. https:\/\/doi.org\/10.1093\/ndt\/gfh161","journal-title":"Nephrol Dial Transplant"},{"key":"4579_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2215\/cjn.00350106","volume":"2","author":"AA Ejaz","year":"2007","unstructured":"Ejaz AA, Mu W, Kang DH et al (2007) (2007) Could uric acid have a role in acute renal failure? Clin J Am Soc Nephrol 2:16\u201321. https:\/\/doi.org\/10.2215\/cjn.00350106","journal-title":"Clin J Am Soc Nephrol"},{"key":"4579_CR10","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1523-1755.2005.00074.x","volume":"67","author":"LG Sanchez-Lozada","year":"2005","unstructured":"Sanchez-Lozada LG, Tapia E, Santamaria J, Avila-Casado C, Soto V, Nepomuceno T, Rodriguez-Iturbe B, Johnson RJ, Herrera-Acosta J (2005) Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int 67:237\u2013247. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00074.x","journal-title":"Kidney Int"},{"key":"4579_CR11","doi-asserted-by":"publisher","first-page":"F116","DOI":"10.1152\/ajprenal.00160.2006","volume":"292","author":"CA Roncal","year":"2007","unstructured":"Roncal CA, Mu W, Croker B, Reungjui S, Ouyang X, Tabah-Fisch I, Johnson RJ, Ejaz AA (2007) Effect of elevated serum uric acid on cisplatin-induced acute renal failure. Am J Physiol Renal Physiol 292:F116\u2013122. https:\/\/doi.org\/10.1152\/ajprenal.00160.2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"4579_CR12","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s10067-018-3991-8","volume":"37","author":"AL Calich","year":"2018","unstructured":"Calich AL, Borba EF, Ugolini-Lopes MR, da Rocha LF, Bonfa E, Fuller R (2018) Serum uric acid levels are associated with lupus nephritis in patients with normal renal function. Clin Rheumatol 37:1223\u20131228. https:\/\/doi.org\/10.1007\/s10067-018-3991-8","journal-title":"Clin Rheumatol"},{"key":"4579_CR13","doi-asserted-by":"publisher","first-page":"R116","DOI":"10.1186\/ar2775","volume":"11","author":"D Daoussis","year":"2009","unstructured":"Daoussis D, Panoulas V, Toms T, John H, Antonopoulos I, Nightingale P, Douglas KM, Klocke R, Kitas GD (2009) Uric acid is a strong independent predictor of renal dysfunction in patients with rheumatoid arthritis. Arthritis Res Ther 11:R116. https:\/\/doi.org\/10.1186\/ar2775","journal-title":"Arthritis Res Ther"},{"key":"4579_CR14","doi-asserted-by":"publisher","first-page":"R83","DOI":"10.1186\/ar3806","volume":"14","author":"KH Yu","year":"2012","unstructured":"Yu KH, Kuo CF, Luo SF, See LC, Chou IJ, Chang HC, Chiou MJ (2012) Risk of end-stage renal disease associated with gout: a nationwide population study. Arthritis Res Ther 14:R83. https:\/\/doi.org\/10.1186\/ar3806","journal-title":"Arthritis Res Ther"},{"key":"4579_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","volume":"76","author":"P Richette","year":"2017","unstructured":"Richette P, Doherty M, Pascual E et al (2017) 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis 76:29\u201342. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209707","journal-title":"Ann Rheum Dis"},{"key":"4579_CR16","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1136\/ard.2006.054593","volume":"66","author":"R Watts","year":"2007","unstructured":"Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W, Mahr A, Segelmark M, Cohen-Tervaert JW, Scott D (2007) Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66:222\u2013227. https:\/\/doi.org\/10.1136\/ard.2006.054593","journal-title":"Ann Rheum Dis"},{"key":"4579_CR17","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/art.1780330807","volume":"33","author":"RY Leavitt","year":"1990","unstructured":"Leavitt RY, Fauci AS, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 33:1101\u20131107. https:\/\/doi.org\/10.1002\/art.1780330807","journal-title":"Arthritis Rheum"},{"key":"4579_CR18","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1136\/ard.2008.101279","volume":"68","author":"C Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Lee R, Brown D et al (2009) Modification and validation of the Birmingham vasculitis activity score (version 3). Ann Rheum Dis 68:1827\u20131832. https:\/\/doi.org\/10.1136\/ard.2008.101279","journal-title":"Ann Rheum Dis"},{"key":"4579_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","volume":"90","author":"L Guillevin","year":"2011","unstructured":"Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Le Toumelin P (2011) The five-factor score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore) 90:19\u201327. https:\/\/doi.org\/10.1097\/MD.0b013e318205a4c6","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"4579_CR20","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1002\/1529-0131(200104)44:4<912::AID-ANR148>3.0.CO;2-5","volume":"44","author":"John H. Stone","year":"2001","unstructured":"Stone JH, Hoffman GS, Merkel PA et al (2001) A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score International Network for the Study of the Systemic Vasculitides (INSSYS). Arthritis Rheum 44:912\u2013920. https:\/\/doi.org\/10.1002\/1529-0131(200104)44:4%3c912::Aid-anr148%3e3.0.Co;2-5","journal-title":"Arthritis & Rheumatism"},{"key":"4579_CR21","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrrheum.2017.140","volume":"13","author":"X Bossuyt","year":"2017","unstructured":"Bossuyt X, Cohen Tervaert JW, Arimura Y et al (2017) Position paper: revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis. Nat Rev Rheumatol 13:683\u2013692. https:\/\/doi.org\/10.1038\/nrrheum.2017.140","journal-title":"Nat Rev Rheumatol"},{"key":"4579_CR22","doi-asserted-by":"publisher","first-page":"656","DOI":"10.2741\/3950","volume":"17","author":"M Jin","year":"2012","unstructured":"Jin M, Yang F, Yang I, Yin Y, Luo JJ, Wang H, Yang XF (2012) Uric acid, hyperuricemia and vascular diseases. Front Biosci (Landmark Ed) 17:656\u2013669","journal-title":"Front Biosci (Landmark Ed)"},{"key":"4579_CR23","doi-asserted-by":"publisher","unstructured":"(2013) Chapter 1: Definition and classification of CKD. Kidney Int Suppl (2011) 2013;3:19\u201362. https:\/\/doi.org\/10.1038\/kisup.2012.64","DOI":"10.1038\/kisup.2012.64"},{"key":"4579_CR24","first-page":"93","volume":"24","author":"C Mukhtyar","year":"2006","unstructured":"Mukhtyar C, Hellmich B, Jayne D, Flossmann O, Luqmani R (2006) Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis. Clin Exp Rheumatol 24:93\u201398","journal-title":"Clin Exp Rheumatol"},{"key":"4579_CR25","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/S0272-6386(04)00934-5","volume":"44","author":"K Iseki","year":"2004","unstructured":"Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S (2004) Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 44:642\u2013650","journal-title":"Am J Kidney Dis"},{"key":"4579_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000484277","volume":"192","author":"K Iseki","year":"2018","unstructured":"Iseki K (2018) Significance of hyperuricemia among community-based screening participants. Contrib Nephrol 192:41\u201347. https:\/\/doi.org\/10.1159\/000484277","journal-title":"Contrib Nephrol"},{"key":"4579_CR27","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fmed.2018.00160","volume":"5","author":"CL Benn","year":"2018","unstructured":"Benn CL, Dua P, Gurrell R, Loudon P, Pike A, Storer RI, Vangjeli C (2018) Physiology of hyperuricemia and urate-lowering treatments. Front Med (Lausanne) 5:160. https:\/\/doi.org\/10.3389\/fmed.2018.00160","journal-title":"Front Med (Lausanne)"},{"key":"4579_CR28","doi-asserted-by":"publisher","first-page":"6681","DOI":"10.1038\/s41598-019-43241-3","volume":"9","author":"TR Oh","year":"2019","unstructured":"Oh TR, Choi HS, Kim CS, Bae EH, Ma SK, Sung SA, Kim YS, Oh KH, Ahn C, Kim SW (2019) Hyperuricemia has increased the risk of progression of chronic kidney disease: propensity score matching analysis from the KNOW-CKD study. Sci Rep 9:6681. https:\/\/doi.org\/10.1038\/s41598-019-43241-3","journal-title":"Sci Rep"},{"key":"4579_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev-pathol-011811-132453","volume":"8","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Hu P, Xiao H (2013) Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis. Annu Rev Pathol 8:139\u2013160. https:\/\/doi.org\/10.1146\/annurev-pathol-011811-132453","journal-title":"Annu Rev Pathol"},{"key":"4579_CR30","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrrheum.2014.103","volume":"10","author":"JC Jennette","year":"2014","unstructured":"Jennette JC, Falk RJ (2014) Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease. Nat Rev Rheumatol 10:463\u2013473. https:\/\/doi.org\/10.1038\/nrrheum.2014.103","journal-title":"Nat Rev Rheumatol"},{"key":"4579_CR31","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/BOR.0b013e32835cedd4","volume":"25","author":"TJ Gibson","year":"2013","unstructured":"Gibson TJ (2013) Hypertension, its treatment, hyperuricaemia and gout. Curr Opin Rheumatol 25:217\u2013222. https:\/\/doi.org\/10.1097\/BOR.0b013e32835cedd4","journal-title":"Curr Opin Rheumatol"},{"key":"4579_CR32","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1751-7176.2012.00674.x","volume":"14","author":"MA McAdams-DeMarco","year":"2012","unstructured":"McAdams-DeMarco MA, Maynard JW, Baer AN, Coresh J (2012) Hypertension and the risk of incident gout in a population-based study: the atherosclerosis risk in communities cohort. J Clin Hypertens (Greenwich) 14:675\u2013679. https:\/\/doi.org\/10.1111\/j.1751-7176.2012.00674.x","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"4579_CR33","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/BOR.0b013e32835d951e","volume":"25","author":"C Li","year":"2013","unstructured":"Li C, Hsieh MC, Chang SJ (2013) Metabolic syndrome, diabetes, and hyperuricemia. Curr Opin Rheumatol 25:210\u2013216. https:\/\/doi.org\/10.1097\/BOR.0b013e32835d951e","journal-title":"Curr Opin Rheumatol"},{"key":"4579_CR34","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1136\/heartjnl-2012-302535","volume":"99","author":"M Kanbay","year":"2013","unstructured":"Kanbay M, Segal M, Afsar B, Kang DH, Rodriguez-Iturbe B, Johnson RJ (2013) The role of uric acid in the pathogenesis of human cardiovascular disease. Heart 99:759\u2013766. https:\/\/doi.org\/10.1136\/heartjnl-2012-302535","journal-title":"Heart"},{"key":"4579_CR35","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1681\/asn.2014070660","volume":"26","author":"ME Kleber","year":"2015","unstructured":"Kleber ME, Delgado G, Grammer TB, Silbernagel G, Huang J, Kramer BK, Ritz E, Marz W (2015) Uric acid and cardiovascular events: a mendelian randomization study. J Am Soc Nephrol 26:2831\u20132838. https:\/\/doi.org\/10.1681\/asn.2014070660","journal-title":"J Am Soc Nephrol"},{"key":"4579_CR36","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.rdc.2019.04.005","volume":"45","author":"D Albert","year":"2019","unstructured":"Albert D, Scudder PN, Bagley P, Saag KG (2019) Vascular consequences of hyperuricemia and hypouricemia. Rheum Dis Clin North Am 45:453\u2013464. https:\/\/doi.org\/10.1016\/j.rdc.2019.04.005","journal-title":"Rheum Dis Clin North Am"},{"key":"4579_CR37","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1053\/j.ajkd.2018.02.362","volume":"72","author":"HR Yun","year":"2018","unstructured":"Yun HR, Kim H, Park JT et al (2018) Obesity, metabolic abnormality, and progression of CKD. Am J Kidney Dis 72:400\u2013410. https:\/\/doi.org\/10.1053\/j.ajkd.2018.02.362","journal-title":"Am J Kidney Dis"},{"key":"4579_CR38","doi-asserted-by":"publisher","first-page":"39","DOI":"10.23876\/j.krcp.2017.36.1.39","volume":"36","author":"H Kim","year":"2017","unstructured":"Kim H, Kim J, Seo C et al (2017) Body mass index is inversely associated with mortality in patients with acute kidney injury undergoing continuous renal replacement therapy. Kidney Res Clin Pract 36:39\u201347. https:\/\/doi.org\/10.23876\/j.krcp.2017.36.1.39","journal-title":"Kidney Res Clin Pract"},{"key":"4579_CR39","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1681\/asn.2013070754","volume":"25","author":"JL Lu","year":"2014","unstructured":"Lu JL, Kalantar-Zadeh K, Ma JZ, Quarles LD, Kovesdy CP (2014) Association of body mass index with outcomes in patients with CKD. J Am Soc Nephrol 25:2088\u20132096. https:\/\/doi.org\/10.1681\/asn.2013070754","journal-title":"J Am Soc Nephrol"},{"key":"4579_CR40","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1681\/asn.2011111078","volume":"23","author":"JL Babitt","year":"2012","unstructured":"Babitt JL, Lin HY (2012) Mechanisms of anemia in CKD. J Am Soc Nephrol 23:1631\u20131634. https:\/\/doi.org\/10.1681\/asn.2011111078","journal-title":"J Am Soc Nephrol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04579-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-020-04579-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04579-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T23:38:41Z","timestamp":1618875521000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-020-04579-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,20]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["4579"],"URL":"https:\/\/doi.org\/10.1007\/s00296-020-04579-4","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"type":"print","value":"0172-8172"},{"type":"electronic","value":"1437-160X"}],"subject":[],"published":{"date-parts":[[2020,4,20]]},"assertion":[{"value":"27 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was performed in accordance with the principles set by the Declaration of Helsinki, and was approved by the Institutional Review Board (IRB) of Severance Hospital (IRB number: 4-2017-0673).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The data that support the findings of this study are available from the corresponding author upon reasonable request.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data and\/or Code availability"}}]}}